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ABSTRACT
Objectives Common mental disorders (CMDs) are a
major cause of rising disability beneﬁt expenditures. We
urgently need evidence on programmes that can increase
work participation in CMDs. The aim of this study was
to evaluate the effectiveness of work-focused cognitive–
behavioural therapy (CBT) and individual job support for
people struggling with work participation due to CMDs.
Methods A randomised controlled multicentre trial
(RCT) including 1193 participants was conducted.
Participants were on sick leave, at risk of going on sick
leave or on long-term beneﬁts. The intervention
integrated work-focused CBT with individual job support.
The control group received usual care. The main
outcome was objectively ascertained work participation
at 12 months follow-up, with changes in mental health
and health-related quality of life as secondary outcomes.
Results A larger proportion of participants in the
intervention group had increased or maintained their
work participation at follow-up compared to the control
group (44.2% vs 37.2%, p=0.015). The difference
remained signiﬁcant after 18 months (difference 7.8%,
p=0.018), and was even stronger for those on long-term
beneﬁts (difference 12.2%, p=0.007). The intervention
also reduced depression (t=3.23, p≤0.001) and anxiety
symptoms (t=2.52, p=0.012) and increased health-
related quality of life (t=2.24, p=0.026) more than usual
care.
Conclusions A work-focused CBT and individual job
support was more effective than usual care in increasing
or maintaining work participation for people with CMDs.
The effects were profound for people on long-term
beneﬁts. This is the ﬁrst large-scale RCT to demonstrate
an effect of a behavioural intervention on work
participation for the large group of workers with CMDs.
Trial registration number ClinicalTrials.gov,
registration number: NCT01146730.
INTRODUCTION
Sickness absence with mental disorders as a
primary diagnosis has increased markedly over the
past decade, and mental and behavioural disorders
now account for more incapacity beneﬁt claims
than any other disorders,1 2 despite no clear
increase in corresponding prevalence rates.3–5
Common mental disorders affect one-sixth of the
working age population at any one point,6 many of
whom struggle to cope with and retain their place
in working life.1 7 As a consequence, these disor-
ders represent a signiﬁcant loss of labour supply
and increase state expenditure through sickness
absence and disability pensions.1 With longer sick-
ness absences, it becomes less likely that the person
will return to work (RTW).8 9 A crucial challenge
is therefore to disrupt the process of prolonged
sickness absence before it progresses into perman-
ent disability.7
Cognitive–behavioural therapy (CBT) is estab-
lished as standard treatment for depression10 and
anxiety.11 There is, however, no one-to-one rela-
tionship between disorder, symptom levels and
work participation,7 and it is not clear if treatment
and remission of a common mental disorder, such
as by way of CBT, results in increased work partici-
pation for the individual. Occupational rehabilita-
tion has often followed a ‘two-phased approach’,
with an initial medical goal of alleviating health
problems, whereupon the individual with or
without further assistance is expected to RTW.
Recent evidence challenges this as early re-entry to
ordinary employment with close follow-up can
increase both work participation12–15 and mental
health outcomes16 in severe mental disorders. It is
not known if this approach can be extended to
common mental disorders. In the light of the high
prevalence of common mental disorders and their
What this paper adds
▸ Common mental disorders are a major cause of
rising disability beneﬁt expenditures.
▸ We urgently need evidence on programmes
that can increase work participation in common
mental disorders.
▸ An integrated model of work-focused
cognitive–behavioural therapy and individual
job support, emphasising early re-entry, was
more effective than usual care in increasing or
maintaining work participation for people with
common mental disorders.
▸ The effects were profound for people on
long-term beneﬁts.
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major impact on sickness absence and disability pension award,
efﬁcacious interventions to restore working capacity and prevent
ill health retirement for this patient group are needed.
The main objective of this study was to evaluate the effective-
ness of an integrated model (work-focused CBT and individual
job support), labelled AWaC (At Work and Coping), for people
struggling with work participation due to common mental dis-
orders. The effect was evaluated in a pragmatic randomised con-
trolled multicentre trial (RCT), to reach robust conclusions in
an ecologically valid study setting. Participants were randomised
to AWaC or usual care provided by the Norwegian Labor and
Welfare Administration (NAV) and/or general practitioners
(GPs).
Primary objective: (1) To investigate the main effect of AWaC
on work participation at 12 months follow-up.
Secondary objectives: (1) to investigate changes in mental
health and health-related quality of life at 12 months follow-up;
(2) to calculate the cost-effectiveness of AWaC and (3) to
examine effect differences in subgroups deﬁned by gender, age,
baseline work status, health variables and time of inclusion.
METHODS
Study context
The Norwegian public insurance system includes all lawful resi-
dents of Norway and provides health service beneﬁts and pen-
sions for all members of the National Insurance Scheme,
administered by the Norwegian Welfare and Labor
Administration (NAV). The workers’ compensation programme
is part of the scheme and provides 100% coverage for lost
income due to medically acknowledged sickness, disease or
injury (including mental illness) from day one until the person
can work again, up to 52 weeks. After that, long-term beneﬁts
provide approximately 66% of former income.
Procedure
People aged 18–60 years who were struggling with work partici-
pation attributable to common mental disorders were invited.
This included people on and at risk of sick leave, as well as
people on long-term beneﬁts (primarily participants on work
assessment allowance after >12 months sick leave). During the
ﬁrst assessment of eligibility, a clinical psychologist assessed the
presence of common mental disorders. This assessment was
based on informal self-reports of symptoms and symptoms con-
sistent with anxiety and/or depression. This included the sub-
threshold symptoms of anxiety and depression disorders, as
they too are strongly associated with functional disability and
absence from work.17 Eligible participants had to express a
motivation to RTW/stay at work. Participants were excluded if
reasons other than common mental disorders were the primary
cause of problems with work participation, such as no motiv-
ation to participate in working life; severe psychiatric disorders;
high suicide risk; pregnancy and ongoing substance abuse.
Inability to read Norwegian and engagement in psychotherapy
elsewhere also led to exclusion.
1416 potential participants were referred and considered for
inclusion (6/1/2010–2/1/2012). Of these, 197 did not fulﬁl the
inclusion criteria, 17 did not consent to participate, and 9 with-
drew their consent and required data deletion (see online
supplementary ﬁgure). In total, 1193 participants entered the
trial and were randomised, 52.8% (n=630) to the intervention
group and 47.2% (n=563) to the control group. The unba-
lanced allocation (a 2:1 randomisation ratio in the ﬁrst
5 months of recruitment) ensured that the centres could run
according to maximal capacity. The randomisation procedure
strictly adhered to the formal requirements of adequate random-
isation at all times (see online supplementary ﬁle for the full
trial protocol).
Of the 1193 participants, 336 (32%) were referred from NAV,
238 (23%) from their GP, 351 (22%) were self-referred, 124
(12%) got referred from other service providers, and 144 parti-
cipants did not inform on the pathway to the trial.
Potential participants were informed about the project and
screened for inclusion and exclusion criteria at the centres by a
clinical psychologist. Eligible and willing participants signed the
informed consent and completed the baseline questionnaire.
After random allocation, participants were informed about the
outcome, and the intervention group was given a date for its
ﬁrst session.
Ethical considerations
The research was carried out in compliance with all principles
in the Helsinki declaration. Personal conﬁdentiality was guaran-
teed, and informed consent was signed by each participant with
emphasis on the right to withdraw from the study at any time
without any explanation.
Interventions
The AWaC programme provides a systematic approach where
individual CBT and job support are integrated. Miniteams of
therapists and employment specialists were formed at each
centre to ensure integration between CBT and the explicit work
focus. CBT was characterised by ‘cognitive work-coping’, and
focused on managing mental health problems as they relate to
work situations. Up to 15 sessions of CBT were offered. The
individual job support was based on the ‘Individual Placement
and Support (IPS)’ approach, developed for people with severe
mental illness,18 and was offered to those in need of individual
job support (primarly participants on long-term disability) to
facilitate workplace adaptations or identiﬁcation of appropriate
employment. IPS represents a relatively new approach to voca-
tional rehabilitation and incorporates the following eight princi-
ples: eligibility based on consumer choice, focus on competitive
employment, integration of mental health and employment ser-
vices, attention to client preferences, work incentives planning,
rapid job search, systematic job development and individualised
job support. The IPS framework is less speciﬁc on choice of
therapeutic approach within the mental health services. The
integration of the IPS principles and work-focused CBT in the
AWaC thus represents a unique and innovative elaboration of
the IPS model for people with common mental disorders
(extensive information available in the study protocol, online
supplementary ﬁle, pp.23–37).
Patients allocated to the control group received standard treat-
ment from their GP, national insurance ofﬁce (NAV), other
health professionals, and received a letter with information and
encouragement to use available services and self-help resources.
Employment and health care services for the control group
were not restricted (beyond ruling out the AWaC), they could
well be followed up by other psychologists and/or participate in
other employment schemes initiated by NAV. The control condi-
tion thus represents an active, as opposed to passive, control
condition, and illustrates how the main distinguishing feature of
the AWaC is the systematic and integrated approach.
Outcomes
Using data from the national social insurance register and the
national employee register, we could (with no loss to follow-up)
determine if a person (1) was in regular work (part time or full
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time), (2) was in combined work and a recipient of beneﬁts, or
(3) was out of work, with or without social insurance beneﬁts.
The primary outcome was ‘increased or maintained work par-
ticipation’ at 12 months post baseline, operationalised as main-
tained work participation, new employment or a full or partial
RTW, depending on the individual’s baseline work status. Full
or partial RTW was operationalised as: working and no recep-
tion of health-related or work-related beneﬁts, or reduced
beneﬁt coverage and increased work participation compared
with baseline status. This information was collected for each
month of follow-up, up until 18 months, to examine sensitivity
of the primary 12 months results.
The secondary outcome measures were questionnaire-based
changes in psychological distress, and symptoms of anxiety and
depression by use of the Hospital Anxiety and Depression
(HAD) Scale.19 20 EQ5D was used to measure changes in
health-related quality of life.21 Self-report questionnaires were
administered to the patients at baseline and after 6 and
12 months.
Sample size
The commisioning body predicted that the AWaC centres would
recruit 600–1000 participants/year. On the basis of an optimistic
8% effect difference in favour of AWaC versus control (48% vs
40% increased work participation), we calculated that a sample
size of 600 in each group would be sufﬁcient to detect statistic-
ally signiﬁcant results.
Randomisation
The participants were randomised with a computer-generated
randomisation list stratiﬁed by centre. At each centre, the person
responsible for inclusion emailed the research unit, presented
the participant’s project ID number, name and gender before
treatment allocation was disclosed. The allocation code, includ-
ing details of block size (10), was not revealed to the researchers
or the clinicians until recruitment and data collection were
complete.
Statistical methods
For the main effect analysis, we observed crude rates of partici-
pants with increased work participation in the two groups. The
effects of treatment were further examined by logistic and multi-
nomial logistic regression analyses when adjusting for minor
by-chance remaining differences in observed characteristics
between the intervention group and the control group. 95% CIs
were based on SEs obtained from logistic and multinomial logis-
tic regressions estimated separately for each calendar month
during 12–18 months after inclusion and corrected for cluster-
ing on site. For the secondary outcomes (mental health), we per-
formed analyses with inverse probability weights22 to account
for possible attrition bias. Analyses adhered to the
‘intention-to-treat’ principle. The authors in charge of the data
analysis were blinded for intervention assignment. Data were
analysed using STATAV.12.
To test for potential subgroup effects of the AWaC pro-
gramme, characteristics prespeciﬁed in the protocol (gender and
age, work status at baseline, inclusion early vs late in the project
period, and also duration and intensity of mental health symp-
toms) were entered in the regression model and assessed for
potential inﬂuence on the main effect. Baseline work status was
considered of particular importance and the effects are also pre-
sented in tables stratiﬁed on this variable.
Treatment adherence
Only 5% dropped out of treatment (completing <3 sessions) in
the AWaC group. Treatment adherence in the control group was
not registered.
Eligibility criteria for care providers
All therapists were monitored, videotaped and scored according
to the Cognitive Therapy Adherence and Competence Scale23
prior to the trial enrolment. The AWaC CBT protocol was clearly
deﬁned from the outset. The employment specialists were
required to have relevant qualiﬁcations and broad experience
with supported employment, and extensive knowledge regarding
the IPS principles24 and the job market in the team’s region.
Details on capacity
Maximum client capacity for the six centres varied. At the most,
85 clients were enrolled at one centre, whereas the peak for the
lowest ranking centre was 43 enrolled at the same time.
Cost-beneﬁt analysis of the impact of treatment
We calculated the economic returns of AWaC compared with
usual treatment by a standard cost-beneﬁt formula based on the
human capital approach.25–27 Economic beneﬁts from treatment
were calculated by multiplying treatment effects by the dis-
counted net present value of productivity gains when a person
works instead of receiving disability pension. Treatment effects
were measured as the observed differences in RTW between the
AWaC and the control group, averaged over the 12–18 months
after enrolment. The estimate of the net present value of prod-
uctivity gains were based on means of the group-speciﬁc
observed annual income the year before enrolment, measured in
Norwegian Krone (NoK) 2012. Estimates of productivity gains
from work were based on annual income the year before inclu-
sion. For a single worker, the productivity gain per year is the
sum of annual gross earnings and social costs of labour,
the latter represented by the payroll tax paid by the employer.
In compliance with ofﬁcial recommendations (Ministry of
Finance, 2005), the marginal cost of public funds was set at 0.2,
whereas the social discount rate was set at 0.04.
Costs of the AWaC programme included the total cost of treat-
ment and follow-up at the centres, as well as the cost of additional
treatment and follow-up by NAVand/or primary healthcare provi-
ders such as GPs, psychologists, physiotherapists and chiroprac-
tors. The costs of usual care included costs of treatment and
follow-up by NAVand/or healthcare providers. Information about
additional treatment and follow-up by NAV was collected from
registers while information about healthcare services was collected
through follow-up questionnaires. Information about costs per
month for services and participation in labour market programmes
provided by NAV, and about costs per consultation for healthcare
services, were obtained from NAV.
Calculations of costs and beneﬁts were based on annual pro-
duction estimates when assuming that the centres can treat and
follow-up 615 persons/year. Costs were measured in 2011
(index year). Beneﬁts were calculated in 2012 and discounted to
2011. We performed an external economic evaluation based on
the overall effect, as well as an internal economic evaluation
based on the effect observed for participants who had been out
of work for more than 12 months. While the former yields the
net economic returns of the experiment, the latter approximates
the economic returns of treatment if given only to persons on
long-term beneﬁts, who otherwise fulﬁlled the inclusion criteria
used in the current study.
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RESULTS
Loss to follow-up
Data on the main outcome measure, work participation, were
complete for all participants. However, for secondary outcomes
based on self-report, 740 (62%) participants at 6 months
follow-up and 636 (52%) participants at 12 months follow-up
returned their questionnaires (see ﬂow chart, online
supplementary ﬁgure).
Participant characteristics
More women (67%) than men (33%) were referred and
included in the trial. Mean age was 40.4 years (95% CI 39.9 to
41.0) and on average participants reported having had psycho-
logical symptoms for 8.6 years (SD=9.76). At baseline, 31.4%
of the participants were working (of these, 48% were combining
work and sick leave), 39% were fully on sick leave, 21.7% were
on long-term beneﬁts (>12 months sick leave) and 7.9% were
unemployed (table 1). In the subgroup analyses, the unemployed
people are included in the group on long-term beneﬁts.
Implementation of intervention
In the AWaC group, all received CBT delivered by a clinical psych-
ologist/counsellor, and 32% also received individual job support.
In addition, many also received other interventions from NAVand
health services (see online supplementary table S1). Services
provided for controls may have assimilated the intervention, but as
the key element of AWaC was the integration of CBTand individ-
ual job support, the degree and impact of potential contamination
was considered minimal.
Qualitative assessments in the early phase of the trial sug-
gested challenges with implementation of the job support ele-
ments, but no ﬁdelity assessments using the IPS ﬁdelity scale24
were conducted at baseline as the employment intervention was
being developed throughout the trial. Fidelity was, however,
assessed postrecruitment, with results showing satisfactory
quality and adherence to IPS. Still, there was no enrolment
time×group allocation interaction (p=0.207).
In the control group, NAV deployed a total of 255 interven-
tions in 157 individuals, the most common being work with
assistance, labour market courses, traineeship and educational
interventions. The AWaC protocol did not restrict use of other
interventions, and the corresponding ﬁgures for the AWaC
group were 206 interventions for 143 individuals. The control
group reported a higher use of health services than the AWaC
group (see online supplementary table S1).
Number of care providers performing the treatment in each
group
The average number of employment specialists during the trial
period was 5.7 full-time equivalents (FTEs) distributed across
Table 1 Baseline characteristics of participants
AWaC Control
n Per cent n Per cent
Female 437 69.37 365 65.01
Married 189 30.00 184 32.68
Age (years)
<30 105 16.66 87 15.45
30–39 220 34.92 169 30.01
40–49 198 31.42 185 32.85
50+ 107 16.98 122 21.66
Education
Primary 49 7.78 36 6.39
Senior high 196 31.11 187 33.21
University/college 353 56.03 304 54.00
Other 30 4.76 35 6.22
Missing data 2 0.32 1 0.18
Self-assessed health
Good 236 37.46 208 36.94
Medium 301 47.78 248 44.05
Poor 86 13.65 104 18.47
Missing data 7 1.11 3 0.53
Employment status
Work
Work, no benefits 104 16.51 88 15.63
Combined work and sick leave benefits 95 15.10 88 15.63
Fully on sick leave 254 40.16 210 37.30
Long-term health benefits 131 20.79 128 22.74
Unemployed 46 7.30 49 8.70
Mean 95% CI Mean 95% CI
Anxiety (HADS) 10.51 10.21 to 10.82 10.86 10.52 to 11.20
Depression (HADS) 7.76 7.45 to 8.07 8.44 8.10 to 8.78
HADS total score 18.27 17.74 to 18.80 19.29 18.71 to 19.88
AWaC, At Work and Coping; HADS, Hospital Anxiety and Depression Scale.
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nine people. The average number of therapists providing the
work-focused CBTwas 20 (20 FTEs), with each therapist treat-
ing 30 participants on average during the trial period.
Primary outcome measure
At 12 months, the proportion with increased or maintained
work participation was higher in the AWaC group than in the
control group (44.2% vs 37.2%, difference 6.9%, p=0.015),
and this difference remained at 18 months (difference 7.8%,
p=0.018; ﬁgure 1). The effect difference remained statistically
signiﬁcant in adjusted models at 12 months (table 2).
The difference between the AWaC group and the control
group was largest for those on long-term beneﬁts at baseline,
with 24% increased or maintained work participation in the
AWaC group compared with 12% in the control group at
12 months (ﬁgure 2). The difference increased to 30% versus
11% at 18 months follow-up. There was no statistically
signiﬁcant effect difference between AWaC and controls in the
other subgroups (on sick leave and at risk of going on sick
leave). There were no signiﬁcant effect differences in subgroup
analyses based on gender, age, time of inclusion or health status
at baseline.
Secondary outcome measures
The AWaC group reported signiﬁcant improvements in mental
health and a higher mean health-related quality of life at the
12-month follow-up (table 3), also after control for baseline
scores. Adjusting for attrition using inverse probability weights
based on demographics (age, gender, education) and the out-
comes of interest (psychological distress, anxiety and depression
symptoms) did not alter the results.
We observed no increased effect for the subgroup on long-
term beneﬁts regarding symptoms of mental health or
health-related quality of life.
Table 2 Effects of treatment in AWaC versus treatment as usual on probability of increased or maintained work participation, calculated from
logistic and multinomial regression estimates. Marginal effects, evaluated at sample mean of regressors
Increased/maintained work Fully in work Partly in work
Month Marginal effect 95% CI Marginal effect 95% CI Marginal effect 95% CI
All participants
12 0.062 0.005 to 0.118 0.034 −0.026 to 0.095 0.025 −0.014 to 0.064
13 0.056 0.000 to 0.113 0.035 −0.023 to 0.093 0.019 −0.027 to 0.065
14 0.055 −0.011 to 0.121 0.026 −0.021 to 0.073 0.027 −0.017 to 0.070
15 0.076 0.000 to 0.152 0.057 0.011 to 0.103 0.017 −0.034 to 0.069
16 0.028 −0.049 to 0.104 0.025 −0.031 to 0.081 0.002 −0.041 to 0.044
17 0.065 0.005 to 0.126 0.036 −0.020 to 0.092 0.026 −0.005 to 0.057
18 0.070 −0.024 to 0.165 0.038 −0.041 to 0.118 0.029 −0.007 to 0.065
Participants on long-term benefits
12 0.074 0.011 to 0.137 0.002 −0.042 to 0.047 0.058 0.002 to 0.115
13 0.096 0.025 to 0.168 0.025 −0.025 to 0.075 0.058 −0.003 to 0.119
14 0.087 −0.004 to 0.178 0.029 −0.044 to 0.103 0.048 −0.016 to 0.112
15 0.111 0.019 to 0.204 0.044 −0.041 to 0.129 0.056 −0.013 to 0.124
16 0.120 0.009 to 0.230 0.058 −0.043 to 0.159 0.054 −0.009 to 0.116
17 0.159 0.060 to 0.258 0.081 0.012 to 0.151 0.065 −0.010 to 0.141
18 0.178 0.104 to 0.253 0.091 0.033 to 0.149 0.066 0.004 to 0.127
Separate regression analyses for each calendar month after inclusion. Controls for gender, age, marital status, income prior to inclusion, self-assessed health, expectation of return to
work, work status at inclusion and treatment site. 95% CIs based on robust SEs allowing for correlated residuals within treatment sites.
Figure 1 Full sample. Observed difference in proportions with
increased or maintained work participation, intervention versus controls
(AWaC, At Work and Coping).
Figure 2 Participants on long-term beneﬁts. Observed differences in
proportions with increased or maintained work participation,
intervention versus controls (AWaC, At Work and Coping).
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The probability of receiving IPS was estimated by logistic
regression including employment status at baseline and other
individual characteristics and site as regressors. Persons on long-
term beneﬁts had a higher probability of receiving IPS than the
other subgroups. The probability of receiving IPS was also
higher if scoring ≥8 on HADS anxiety at inclusion. The centres
varied in terms of job support service delivery.
Cost-beneﬁt analyses
Total costs at the six centres included operating expenses, wage
payments and payment for job support services. In 2011, this
amounted in total to NoK 17 246 million (about £1 883 040).
Divided by the expected number of treated patients per year
under normal operating conditions (615), this equates to NoK
28 043 (about £3062) per patient for AWaC. In addition, costs
for society through other services provided by NAV and/or
healthcare providers amounted to NoK 9469 (about £1034) for
each person receiving AWaC (see online supplementary table S2).
Persons referred to treatment as usual received more services
from NAV and had more consultations with psychologists and
other healthcare providers than participants in the treatment
group. In total, costs of treatment per person receiving treatment
as usual amounted to NoK 16 800 (about £1834). Taking the dif-
ference and adjusting for marginal costs of public funds (1
+0.2)×(37 512−16 800), additional costs for the society from
participation in AWaC amounted to NoK 24 854 per person
(about £2713).
Beneﬁts emerged from observed between-group differences in
full RTW (ie, not receiving any sickness beneﬁts) (0.0456) and
partly (0.025) RTW. The net social value of production per
person per year, based on average annual earnings of partici-
pants in the sample (NoK 340 400) and adding social costs, was
(399 664−76 496+0.2×350 240) NoK 39 3216 when there
was full work participation, and multiplied by 0.5 in the case of
partly return to work. Based on this, the average per person
increase in the net present value of production from participa-
tion in AWaC amounted to ((0.044×393 216)/1.04+0×5
(0.024×393 216)/1.04) NoK 21 173 (about £2311). Under the
assumption that treatment effects would last for 1 year, eco-
nomic beneﬁts did not outweight additional costs of participa-
tion in the AWaC programme. On the basis of overall treatment
effects of the assumed 615 persons in treatment/year, the esti-
mated net present value of productivity gains was negative NoK
2 263 815 (about £247 141).
Had AWaC been given only to persons on long-term beneﬁts,
costs for additional services by NAV would have been consider-
ably higher in both treatment groups. The stronger treatment
effects, both in terms of full-time work (0.077) and part time
work (0.072), would, however, generate productivity gains to
more than outweight the additional costs of treatment. In total,
the net present value of the productivity gains with treatment
effects lasting for 1 year amounted to NoK 4 731 810 (about
£516 570).
DISCUSSION
The main aim of this project was to evaluate if the AWaC pro-
gramme, a systematic approach integrating elements from CBT
and IPS, led to increased or maintained work participation for
people with common mental disorders. The results indicated a
signiﬁcant effect in favour of AWaC at 12-month follow-up. In
the group that received AWaC, 44% were fully or partially at
work at 12 months, compared with 37% in the control group.
The main effect remained at 18 months. Further, the effect was
stronger among those on long-term beneﬁts, with 24%
increased or maintained work participation in the AWaC group
compared with 12% in the control group at 12 months, a differ-
ence that increased to 30% versus 11% at 18 months. The
AWaC group also had a more favourable development in terms
of mental health status and health-related quality of life after
12 months. We observed no corresponding larger effect differ-
ence for the group on long-term beneﬁts in terms of symptoms
of mental health or health-related quality of life.
The stronger effect difference for the subgroup on long-term
beneﬁts might have to do with both the intervention better
matching the actual needs for this group, but can also reﬂect
less optimal services in the control condition for this group.
Whether the stronger results were caused by speciﬁc elements in
the intervention cannot be answered by the trial, but we did
ﬁnd a higher probablity of receiving job support in the subgroup
on long-term beneﬁts. This indicates that work is correlated to
job support, but it is impossible to distinguish between a poten-
tial causal effect and correlation coming from job support being
given based on individual characteristics that in and of itself
could be correlated to work.
The cost-beneﬁt analyses did not demonstrate positive eco-
nomic returns of the AWaC programme. However, for the sub-
group on long-term beneﬁts, the stronger effect sizes translated
to a large positive economic net return. These cost-beneﬁt esti-
mates were all based on the assumption of a treatment effect
lasting for 1 year. To the extent a treatment effect outlasts this
1 year assumption, the programme will yield a higher economic
return. Furthermore, we acknowledge that increased employ-
ment not only brings production gains, but also can promote
health and quality of life for the individual. While the latter
effects are not included in the strict economic analysis, these
important gains would certainly add to the monetary ﬁgures.
Table 3 Mean (SE) scores of secondary outcomes after 12 months follow-up*
Outcome Group N Mean SE 95% CI t Test pValue
HAD total AWaC 376 13.00 0.43 12.14 to 13.84 t=3.14, df=625 0.002
Control 251 15.12 0.53 14.08 to 16.16
Depression (HAD-D) AWaC 376 5.11 0.23 4.67 to 5.56 t=3.23, df=625 0.001
Control 251 6.27 0.28 5.72 to 6.81
Anxiety (HAD-A) AWaC 376 7.88 0.24 7.40 to 8.36 t=2.52, df=625 0.012
Control 251 8.86 0.30 8.26 to 9.46
Health-related quality of life (EQ5D) AWaC 376 65.64 1.15 63.38 to 67.90 t=−2.24, df=616 0.026
Control 251 61.57 1.41 58.78 to 64.36
*Inverse probability weights were performed to account for non-response. The weights included demographics (age, gender and education) and the outcomes of interest (psychological
distress, anxiety and depression symptoms).
AWaC, At Work and Coping; HAD, Hospital Anxiety and Depression.
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Earlier this year, the Organization for Economic Cooperation
and Development (OECD) stated that Norway has the highest
level of sickness absence and costs related to lost labour among
all the member countries.1 Common mental disorders contrib-
ute most to the recent rise in expenditures. The report further
concludes that the Norwegian system can contribute to exclu-
sion of people with mental disorders through ‘welfare-traps’ of
disincentives. This context is important to bear in mind when
interpreting the results. The Norwegian welfare system, with
100% compensation of income from day one and a high level
of available services at low cost for the individual, stands out
from other countries. As such, the system can inﬂuence the
achievable effect sizes for interventions in this area. Few previ-
ous intervention projects aiming to increase RTW have been
able to demonstrate signiﬁcant results,28–30 which makes the
present effect stand out as profound and particularly clinically
important in the Norwegian context.
Strengths and limitations
The main strength of the study is the multicentre RCT design and
the large sample size, providing robust data on the effect of the
intervention as deployed in an ecologically valid setting. We
included participants who were struggling, but still working, and
people who were out of work and further away from employment,
as both extremes would be potential targets for the model if
further implemented. The research group was not involved in
running the sites, or in patient treatment, which ensured an inde-
pendent evaluation. A key strength was that loss to follow-up for
the main outcomes was eliminated through the use of registry data.
National registry data provided information about all social
security beneﬁts received during the project period, work par-
ticipation and vocational rehabilitation services. There was,
however, no registry information available for health outcomes
such as use of health services or health status. Data on services
outside those directly related to work participation therefore
relied on self-report, with corresponding potential for measure-
ment error and non-response bias. Staff adherence towards the
IPS components was not evaluated during the project, as devel-
opment and improvement towards the gold standard of IPS for
this new target group was ongoing throughout the project
period. Adherence to the eight IPS principles was, however,
continuously pursued, and any diversions from the IPS princi-
ples are explained in the attached study protocol (see online
supplementary ﬁle).
We chose not to measure staff adherence to the CBT treat-
ment protocol, as the aim was to test the intervention in a
natural setting, rather than to adhere to a stricter efﬁcacy trial.
Streamlining of the intervention was promoted through
monthly seminars for the teams at the centres, with courses
delivered from approved supervisors within the Norwegian
Association for Cognitive Therapy.
Previous research shows that CBT reduces symptoms and
improves function for patients with common mental disor-
ders.31–34 There is some previous evidence that CBT focusing
on work has an effect on reduced sickness absence,35 while
studies with a less pronounced focus on work resumption are
lacking RTW effects. A few previous studies of CBT interven-
tions have indeed failed to demonstrate an increased RTWeffect
in common mental disorders.36–39 A key difference between
those studies and this study is, however, the explicit focus on
work, and the integration of work-focused CBT and individual
job support. No previous studies have ever combined and inte-
grated these two elements for people with common mental dis-
orders. The current trial is the ﬁrst large-scale randomised
controlled study to demonstrate an effect of a behavioural inter-
vention on work participation for the large group of workers
with common mental disorders.
Implications for research and practice
A signiﬁcant implication for both clinicians and those who
struggle with work participation due to common mental disor-
ders is the demonstration of an adequate, efﬁcient and available
intervention. Such interventions have previously been lacking or
at least not delivered systematically.40 Through the AWaC pro-
gramme, participants not only receive support resulting in
increased work participation, but also experience improvements
in mental health and health-related quality of life. In line with
recent OECD recommendations,1 the AWaC programme inte-
grates mental healthcare and rehabilitation services, and incor-
porates concerns for both work and health.
The AWaC trial was the ﬁrst RCT commisioned by the
Norwegian health and welfare authorities. This initiative is
unique in a Norwegian (and probably also international)
context. The experience of successful collaboration between aca-
demic researchers and policymakers, where a novel policy
scheme and intervention underwent rigorous scientiﬁc evalua-
tions before large-scale implementation, has important policy
implications and should serve as an inspiration for further use
of trials in this sector. Beyond strengthening the evidence base,
such collaborations can help bridge the gap between knowledge
and practical application.41
Our main recommendation for future research is thus to run
more trials of this kind to rapidly improve our evidence base on
this vital topic. We recommend using registry-based outcomes
where available, with long-term follow-up whenever possible,
and also further trials and replications where combinations of
CBT and job support are offered. Our results, and the rapidly
growing IPS literature for severe mental disorders, suggest that
this might be a viable route to reduced workforce dropout from
mental disorders.
Common mental disorders are not just an individual clinical
problem; they are also a major challenge for stakeholders in both
the work and health sectors and the society at large. A combined
model of work-focused CBTand individual job support was more
effective than usual care in increasing or maintaining work partici-
pation for people with common mental disorders. The effects
were profound for people on long-term beneﬁts, and translated to
a major net value of productivity gains for this group.
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